News

One Mindtm, a leading mental health and brain research nonprofit, has announced the addition of three seasoned executives and investors, Brad Freer, Katharina Koenig, and Ashwin Vasan, to the ...
Immunic, Inc. ("Immunic" or the "Company") , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, ...
For nearly 50 years, McLeod has been accredited by the Commission on Cancer of the American College of Surgeons. Photo ...
About 40 percent of cancer cases are considered preventable. Try these lifestyle changes to stay healthy.
MD. Among the most promising trends in oncology over the past year is the growing ability to deliver advanced therapies, such as chimeric antigen receptor (CAR) T and bispecific treatments ...
MD, about the power of information in personalized oncology care, understanding the impacts of genetic testing and more. Sadie Dobrozsi, MD, is a board-certified pediatric oncologist, a nationally ...
Dr. Tamara Schwartz, Professor of Emerging Technology at York College of Pennsylvania, describes the technology as remarkable but raises important questions about data privacy and patient rights.
Dr. M. Blair Marshall, thoracic oncology surgeon with the Jellison Cancer Institute, was the first physician on the Gulf ...
MD, about the role culture plays in improving global oncology, launching the Best of ASCO in Africa and more. Abiola Ibraheem, MD, is a board-certified medical oncologist and assistant professor ...
Guam Regional Medical City announced the addition of Dr. Kin-Sing Au, a board-certified radiation oncologist with more than 30 years of clinical experience in treating cancer, to its growing ...
Brian Slomovitz, MD, of Mount Sinai Medical Center, compares relacorilant plus nab-paclitaxel with existing treatments for platinum-resistant ovarian cancer and highlights the ROSELLA trial’s global ...